While androgen was widely recognized as a poor prognostic marker for the chronic patient (29–31), in the early stage of infection, serum testosterone may protect the male from chronic hepatitis B infection on account of higher SRD5A2 enzyme activity (32). The gene discussed is SRD5A2; the disease is chronic hepatitis B virus infection.